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vascular wall in both groups. Immediately after harvesting, we found
the mRNA signal. After 15 min to 1 hour, the expression was
downregulated.
CONCLUSION Based on our analyses, we can conclude that in case of
conventional technique, less damage of SV was observed than in the
case of endoscopic harvesting. All other parameters showed the same
results in both groups.
400.13
Premedication with Steroids and Short-Term and Long-Term
Renal Outcomes After Coronary and Peripheral Angiography
and Intervention
Wendy Bottinor,1 Raveen Chawla,1 Jeremy Turlington,1 Kalpesh Patel,1
Peter Danyi,2 Robert A. Perera,1 Ion S. Jovin1
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Salem, VA
BACKGROUND Limited data exist regarding the outcomes after cor-
onary and peripheral angiography and intervention in patients with a
history of contrast dye allergy who are premedicated with steroids.
METHODS We studied 4367 patients undergoing peripheral or coro-
nary angiography and percutaneous coronary or endovascular inter-
vention at a Veterans’ Affairs Medical Center. We assessed short-term
and long-term outcomes: contrast-induced nephropathy, renal
dysfunction/contrast-induced nephropathy at 3 months, chronic kid-
ney failure necessitating dialysis, and mortality in patients pretreated
and not pretreated with steroids.
RESULTS The study population was predominantly male (98%)
and white (65%) with a mean age of 66 years. Of the total patient
population, 260 (5.9%) of the total subjects had either a contrast
or a seafood/shellfish allergy and were pretreated with steroids.
Of the 4367 subjects, 1962 (45%) had repeat creatinine values at 3
days, and 3100 (70%) had repeat creatinine values at 3 months.
Overall 3 (2.5%) patients in the allergy group and 85 (4%) patients
in the non-allergy group developed contrast-induced nephropathy
at 3 days (P¼0.39). The proportion of patients with nephropathy
at 3 months and of patients who were started on dialysis after 5
years was not significantly different between the 2 groups. After 5
years, 40 (15.4%) patients in the allergy group and 812 (19.8%)
patients in the non-allergy group had died (P¼0.09). After
adjustment for baseline comorbidities, there was a significant in-
verse association between dye allergy/steroid premedication and
death at 5 years (odds ratio 0.72; 95% confidence interval 0.53-1;
P¼0.049).
CONCLUSIONS In this cohort of US veterans, pretreatment with ste-
roids was not associated with the development of renal dysfunction or
the initiation of dialysis. The association between dye allergy, steroids
pretreatment, and mortality needs to be validated in larger cohorts.
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OBJECTIVE Various risk calculators for stroke may not be practical in
planning prevention as these mostly include non-modifiable factors.
We compared 2 popular risk scores for stroke and 5 risk factors scores
(RFS) meant for cardiovascular disease (CVD) with modifiable factors.
We believe that identifying and managing modifiable factors from
other scores may help in better stroke prevention planning.
METHODS We utilized data gathered from patients admitted to Uni-
versity Hospital in Sarajevo between 2014 and 2016. Five RFS, namely,
10-year Framingham CHD, QRISK 2, AHA/ACC ASCVD risk, Framing-
ham ATP III, and EU SCORE, along with CHADS2 and CHA2DS2-VASc
scores were calculated. We entered 5 RFS as dimensions in a hierar-
chical cluster analysis to group people based on their risk of devel-
oping CVD and compared cluster membership cutoffs for CHADS2 and
CHA2DS2-VASc scores.
RESULTS There were 1277 patients in this study, and a majority (65%)
were women. The mean (SD) age of the sample was 56.2 (11.4) years.
Values for each score within each cluster are presented in Table 1.
Obtained clusters were homogenous and were able to classify patients
into 4 clusters, ordered from lowest to highest risk. Cluster 1 con-
tained patients with lowest mean scores, and cluster 4 with highest
mean scores. Stroke and CVD risk scores pointed in the same direction
and could be used in complimentary way.
CONCLUSION This novel method produced good estimates of a pa-
tient’s risk of developing stroke by combining several scores. Since
CHADS2 and CHA2DS2-VASc scores are mostly comprised of non-
modifiable risk factors, other CVD risk scores may provide more in-
sights into stroke risk management. Correctly identifying patients
who truly have a low risk of developing stroke may help a practi-
tioner’s decision about administration of anticoagulants; these could
be safely withheld among those who are at greater risk of harm than
benefit.
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